(Z)-2-氰基-3-羟基-N-(4-(三氟甲基)苯基)丁-2-烯酰胺; (2Z)-2-氰基-3-羟基-N-[4-(三氟甲基)苯基]丁-2-烯酰胺;;
(2Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide; Aubagio; (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide; (Z)-2-Cyano-3-hydroxy-but-2-enoic acid (4-trifluoromethyl-phenyl)-amide; 2-Butenamide, 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-, (2Z)-; (2Z)-2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide; Teriflunomide; (Z)-2-Cyano-a',a',a'-trifluoro-3-hydroxy-p-crotonotoluidide; A771726; Leflunomide Impurity 2; Teriflunomide [INN]; A 771726; (Z)-2-Cyano-alpha'alpha'alpha-trifluoro-3-hydroxy-p-crotonotoluidide; 2-Cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide; Active metabolite of leflunomide; Flucyamide; HMR 1726; Malononitrilamide; N-(4-Trifluoromethylphenyl)-2-cyano-2-hydroxycrotonamide; SU 20; UNII-1C058IKG3B; 2-Butenamide, 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-; (2Z)-2-(hydroxy{[4-(trifluoromethyl)phenyl]amino}methylidene)-3-oxobutanenitrile
-20°C